Cargando…
A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine
Since the first-reported case of Severe Acute Respiratory Distress Syndrome-Coronavirus 2 in December 2019, COVID-19 has caused a global pandemic associated with significant morbidity and mortality. After a year of advances in vaccine research and development, three vaccines for the prevention of CO...
Autores principales: | Rao, Shiavax J., Khurana, Sahiba, Murthy, Gayathri, Dawson, Elliot T., Jazebi, Noushin, Haas, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462911/ https://www.ncbi.nlm.nih.gov/pubmed/34567447 http://dx.doi.org/10.1080/20009666.2021.1954284 |
Ejemplares similares
-
Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine
Publicado: (2022) -
Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
por: Waheed, Sadia, et al.
Publicado: (2021) -
Covid-19-vaccine-pfizer-biontech: Guillain-Barre syndrome: case report
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Guillain Barre Syndrome: case report
Publicado: (2021) -
Treatment guidelines for Guillain–Barré Syndrome
por: Meena, A. K., et al.
Publicado: (2011)